Abstract:Dysfunctional mitochondrial metabolism and sustained de novo lipogenesis are characteristic of non-alcoholic fatty liver disease (NAFLD), a common comorbidity of obesity and type 2 diabetes. We hypothesize that sustained de novo lipogenesis, through its biochemical relationships with mitochondria (e.g., tri-carboxylic acid (TCA) cycle) can contribute to dysfunctional oxidative flux during NAFLD. In study 1, male mice (C57BL/6JN) were fed either a low-fat (LF; 10% fat Kcal), high-fat (HF; 60% fat Kcal), or high-fructose/HF diet (HFr/HF; 34.9% fructose Kcal, 25% fat Kcal) for 24-wks. Liver mitochondria were utilized to determine oxygen consumption and were incubated in a buffer (for 5-min) to determine changes in TCA cycle intermediates, using gas chromatography-mass spectrometry (GC-MS). Plasma and liver samples were utilized for GC-MS based metabolomics and determination of gene and protein expression. In study 2, C57BL/6JN mice were provided 30% fructose in drinking water (FW) for 2-wks to induce hepatic de novo lipogenesis vs. mice given regular water (RW). Liver mitochondria were incubated in a buffer containing 1mM [ 13 C 3 ]pyruvate or 2.5mM [ 13 C 4 ]malate for 5-min. Isotopomer distribution of the TCA cycle intermediates were determined using GC-MS. Both HF and HFr/HF diets resulted in similar degrees of hepatic steatosis. However, lipogenic gene expression ( Scd1, Acyl, Fasn) and fasting plasma β-hydroxybutyrate levels were higher (p<0.001) in HFr/HF vs. HF group. Further, the feeding-to-fasting induction of genes involved in lipid oxidation ( Cpt1α, Lcad, Hmgcs2) was higher (p ≤0.01) in HFr/HF vs. HF livers. After 5-min of incubation, the HFr/HF liver mitochondria had higher (p<0.05) TCA cycle intermediates vs. the HF. The HFr/HF mitochondria also had higher expression of oxidative phosphorylation proteins and higher oxygen consumption rates (OCR), vs. the HF (p<0.05). In study 2, fructose in drinking water induced hepatic de novo lipogenesis. Induction of lipogenesis was also accompanied by higher mitochondrial OCR, higher reactive oxygen species, and higher TCA cycle metabolism (p<0.05). Gene expression of components of the mitochondrial nutrient shuttles ( SLC25A13, MPC1, MPC2, ME1) was upregulated in lipogenic livers (p<0.05). Incorporation of 13 C from [ 13 C 4 ]malate into pyruvate and α-ketoglutarate, indices of malic enzyme and TCA cycle activity, were higher (p<0.05) in lipogenic livers. Similarly, incorporation of 13 C from [ 13 C 3 ]pyruvate into aspartate and citrate, indices of pyruvate carboxylase and pyruvate dehydrogenase activity, were also higher (p<0.05) in lipogenic livers. These results demonstrate that the induction of several facets of mitochondrial oxidative metabolism and de novo lipogenesis accompany a carbohydrate-rich dietary milieu and NAFLD. Sustained induction of both de novo lipogenesis and mitochondrial oxidative function could contribute to the progression of metabolic dysfunction during NAFLD. National Institutes of Health R01 DK112865 This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice

The mitochondrial pyruvate carrier regulates adipose glucose partitioning in female mice

Sex-dependent adipose glucose partitioning by the mitochondrial pyruvate carrier

Disruption of hepatic mitochondrial pyruvate and amino acid metabolism impairs gluconeogenesis and endurance exercise capacity in mice

Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease

Fatty acid oxidation alleviates the energy deficiency caused by the loss of MPC1 in MPC1+/- mice.

The mitochondrial dicarboxylate carrier mediates in vivo hepatic gluconeogenesis

Loss of mitochondrial pyruvate transport initiates cardiac glycogen accumulation and heart failure

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

Impact of sustained de novo lipogenesis on mitochondrial dysfunction and hepatocellular redox during fatty liver disease

Mitochondrial pyruvate carriers are required for myocardial stress adaptation

Hdmcp Uncouples Yeast Mitochondrial Respiration And Alleviates Steatosis In L02 And Hepg2 Cells By Decreasing Atp And H2o2 Levels: A Novel Mechanism For Nafld

Mitochondrial pyruvate metabolism and glutaminolysis toggle steady-state and emergency myelopoiesis

Mitochondrial Pyruvate Carrier 1: a Novel Prognostic Biomarker That Predicts Favourable Patient Survival in Cancer

Screening for new inhibitors of the human Mitochondrial Pyruvate Carrier and their effects on hepatic glucose production and diabetes

Deficiency of the mitochondrial glycerol 3-phosphate dehydrogenase contributes to hepatic steatosis.

Fatty liver is associated with impaired activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial biogenesis in mice

Diminished ketone interconversion, hepatic TCA cycle flux, and glucose production in D-β-hydroxybutyrate dehydrogenase hepatocyte-deficient mice

Adipose Tissues Of Mpc1(+/-) Mice Display Altered Lipid Metabolism-Related Enzyme Expression Levels

The Effects of Long-Term High Fat and/or High Sugar Feeding on Sources of Postprandial Hepatic Glycogen and Triglyceride Synthesis in Mice

Hepatic‐specific Pgc‐1α ablation drives fibrosis in a MASH model